Sargent Bickham Lagudis’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $711K | Hold |
|
|||||
|
2022
Q3 | $787K | Buy |
|
|||||
|
2022
Q2 | $905K | Buy |
|
|||||
|
2022
Q1 | $1.09M | Sell |
|
|||||
|
2021
Q4 | $1.28M | Hold |
|
|||||
|
2021
Q3 | $1.12M | Sell |
|
|||||
|
2021
Q2 | $1.11M | Sell |
|
|||||
|
2021
Q1 | $903K | Hold |
|
|||||
|
2020
Q4 | $985K | Sell |
|
|||||
|
2020
Q3 | $878K | Hold |
|
|||||
|
2020
Q2 | $760K | Hold |
|
|||||
|
2020
Q1 | $691K | Buy |
|
|||||
|
2019
Q4 | $855K | Hold |
|
|||||
|
2019
Q3 | $806K | Hold |
|
|||||
|
2019
Q2 | $677K | Hold |
|
|||||
|
2019
Q1 | $701K | Buy |
|
|||||
|
2018
Q4 | $546K | Hold |
|
|||||
|
2018
Q3 | $621K | Hold |
|
|||||
|
2018
Q2 | $519K | Buy |
|
|||||
|
2018
Q1 | $414K | Sell |
|
|||||
|
2017
Q4 | $433K | Buy |
|
|||||
|
2017
Q3 | $411K | Sell |
|
|||||
|
2017
Q2 | $461K | Buy |
|
|||||
|
2017
Q1 | $351K | Hold |
|
|||||
|
2016
Q4 | $349K | Sell |
|
|||||
|
2016
Q3 | $455 | Sell |
|
|||||
|
2016
Q2 | $382K | Buy |
|
|||||
|
2016
Q1 | $334K | Buy |
|